The Latest Breaking News from BDX

Becton, Dickinson and Company is ready to unveil its fiscal first-quarter earnings soon, and analysts project a double-digit profit drop.

Baxter International has lagged the broader health care sector by a wide margin over the past year, and analysts are taking a guarded stance on its outlook.

Becton, Dickinson & Company is gearing up to announce its Q4 results next month, with analysts calling for a slight dip in profits.

BD (Becton, Dickinson and Company) (NYSE:BDX) on Wednesday said Chris DelOrefice, executive vice president and chief financial officer (CFO), will depart the company effective December 5.

Despite Becton, Dickinson and Company’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Whereas Intuitive Surgical has delivered weaker returns than the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Despite Becton, Dickinson and Company’s weak performance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

As the healthcare industry continues to rebound from global disruptions, companies like Becton, Dickinson, and Company (NYSE:BDX) are reporting robust financial performances that highlight their resilience and strategic adaptability. The company’s stock is trading higher on Thursday on better-than-expected third-quarter 2025 earnings.

Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a single-digit profit dip.